MyFinsight
Home
Blog
About
Short-term marketable
securities
$556,366K
(0.23%↑ Y/Y)
Cash and cash
equivalents
$272,589K
(137.77%↑ Y/Y)
Prepaid expenses and
other current assets
$19,653K
(23.88%↑ Y/Y)
Contract assets
$15,417K
Total property and
equipment
$23,913K
(9.56%↑ Y/Y)
Total current assets
$864,025K
(26.02%↑ Y/Y)
Long-term marketable
securities
$413,934K
(28.50%↑ Y/Y)
Right-of-use assets
$22,179K
(-7.25%↓ Y/Y)
Property and equipment,
net
$8,280K
(-6.11%↓ Y/Y)
Restricted cash
$1,281K
(59.13%↑ Y/Y)
Less accumulated
depreciation and...
$15,633K
(20.19%↑ Y/Y)
Total assets
$1,309,699K
(25.78%↑ Y/Y)
Total liabilities and
stockholders equity
$1,309,699K
(25.78%↑ Y/Y)
Total stockholders
equity
$1,198,905K
(24.93%↑ Y/Y)
Total liabilities
$110,794K
(35.75%↑ Y/Y)
Accumulated deficit
-$947,530K
(-22.66%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$1,670K
(-209.80%↓ Y/Y)
Additional paid-in capital
$2,148,095K
(24.12%↑ Y/Y)
Total current
liabilities
$82,677K
(49.40%↑ Y/Y)
Long-term operating lease
liabilities
$28,117K
(6.99%↑ Y/Y)
Common stock, 0.0001
par value,...
$10K
(11.11%↑ Y/Y)
Accrued liabilities
$50,979K
(35.04%↑ Y/Y)
Accounts payable
$30,508K
(76.65%↑ Y/Y)
Operating lease
liabilities, current
$1,190K
(274.21%↑ Y/Y)
Back
Back
Balance Sheet
IDEAYA Biosciences, Inc. (IDYA)
IDEAYA Biosciences, Inc. (IDYA)
source: myfinsight.com